AMERISAFE (NASDAQ:AMSF – Get Free Report) had its price objective reduced by stock analysts at Truist Financial from $45.00 to $36.00 in a research report issued on Friday,Benzinga reports. The brokerage currently has a “hold” rating on the insurance provider’s stock. Truist Financial’s price objective would indicate a potential upside of 10.67% from the company’s previous close.
A number of other equities analysts also recently issued reports on AMSF. Wall Street Zen raised shares of AMERISAFE from a “sell” rating to a “hold” rating in a report on Saturday, January 31st. Weiss Ratings reiterated a “hold (c-)” rating on shares of AMERISAFE in a research report on Monday, December 29th. Citizens Jmp cut their price objective on shares of AMERISAFE from $60.00 to $55.00 and set a “market outperform” rating for the company in a research report on Friday, January 16th. Citigroup restated a “market outperform” rating on shares of AMERISAFE in a research note on Friday, January 16th. Finally, Morgan Stanley set a $55.00 target price on AMERISAFE in a report on Friday, January 16th. Two research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $48.67.
Read Our Latest Report on AMSF
AMERISAFE Stock Performance
AMERISAFE (NASDAQ:AMSF – Get Free Report) last announced its earnings results on Wednesday, February 25th. The insurance provider reported $0.51 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.57 by ($0.06). The firm had revenue of $81.59 million during the quarter, compared to analysts’ expectations of $80.05 million. AMERISAFE had a return on equity of 15.66% and a net margin of 14.86%. As a group, sell-side analysts predict that AMERISAFE will post 2.45 EPS for the current fiscal year.
Institutional Investors Weigh In On AMERISAFE
Institutional investors and hedge funds have recently bought and sold shares of the business. Clearstead Advisors LLC boosted its stake in shares of AMERISAFE by 142.4% in the fourth quarter. Clearstead Advisors LLC now owns 657 shares of the insurance provider’s stock worth $25,000 after acquiring an additional 386 shares during the period. Hantz Financial Services Inc. boosted its stake in AMERISAFE by 159.6% in the 4th quarter. Hantz Financial Services Inc. now owns 714 shares of the insurance provider’s stock worth $27,000 after purchasing an additional 439 shares during the period. Quarry LP boosted its stake in AMERISAFE by 346.9% in the 3rd quarter. Quarry LP now owns 943 shares of the insurance provider’s stock worth $41,000 after purchasing an additional 732 shares during the period. Kemnay Advisory Services Inc. bought a new stake in shares of AMERISAFE during the fourth quarter valued at approximately $54,000. Finally, GAMMA Investing LLC lifted its holdings in shares of AMERISAFE by 38.6% in the third quarter. GAMMA Investing LLC now owns 1,633 shares of the insurance provider’s stock worth $72,000 after buying an additional 455 shares in the last quarter. 97.41% of the stock is owned by institutional investors.
AMERISAFE News Summary
Here are the key news stories impacting AMERISAFE this week:
- Positive Sentiment: Company raised its quarterly dividend ~5.1% (annualized yield ~4.9%), which supports income-focused investors and signals capital-return confidence. AMERISAFE Increases Dividend by 5.1%
- Positive Sentiment: Revenue and written premiums showed year-over-year growth in Q4 and management highlighted solid ROE on the earnings call — positives for longer-term underwriting trends. Q4 2025 Earnings Call Highlights
- Neutral Sentiment: Full Q4 earnings call and multiple transcripts are available; they provide detail but contain mixed signals (premium growth vs. expense pressure). Useful for investors doing deeper due diligence. Earnings Call Transcript
- Negative Sentiment: Q4 EPS missed consensus ($0.51 vs. ~$0.57); expenses rose, compressing margins despite higher premiums and investment income — the primary near-term driver of the share decline. AMSF Misses on Q4 Earnings Despite Rising Premiums, Hikes Dividend
- Negative Sentiment: Truist cut its price target from $45 to $36 and set a “hold” rating; an analyst downgrade/target cut increases selling pressure and may anchor near-term sentiment. Truist Lowers Price Target
- Negative Sentiment: Short interest rose materially in February (reports show ~372,998 shares at one point, ~2% of float) and there have been recent insider sales; both can amplify downward moves and volatility. Quiver Quant Coverage (contains short/insider data)
- Negative Sentiment: Technically the stock is trading below its 50- and 200-day moving averages, which typically weighs on sentiment and can trigger additional selling from trend-following funds.
About AMERISAFE
Amerisafe, Inc (NASDAQ: AMSF) is a specialty provider of workers’ compensation insurance products and services in the United States. The company focuses on underwriting and managing workers’ compensation policies for small to mid-sized public and private businesses, particularly in higher-hazard industries such as retail, manufacturing, distribution and wholesale. Through its network of independent agents, Amerisafe delivers tailored coverage solutions that combine robust risk management support with loss prevention programs designed to enhance workplace safety.
In addition to core insurance offerings, Amerisafe provides extensive risk control resources, including safety training, on-site consultations and claims management services.
Recommended Stories
- Five stocks we like better than AMERISAFE
- The gold chart Wall Street is terrified of…
- This makes me furious
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for AMERISAFE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMERISAFE and related companies with MarketBeat.com's FREE daily email newsletter.
